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Introduction: With the current hepatitis C (HCV) epidemic in the Appalachian region and the risk
of human immunodeficiency virus (HIV) co-infection, there is a need for increased secondary
prevention efforts. The purpose of this study was to implement routine HIV and HCV screenings
in the urgent care setting through the use of an electronic medical record (EMR) to increase a
provider’s likelihood of testing eligible patients.
Methods: From June 2017 through May 2018, EMR-based HIV and HCV screenings were
implemented in three emergency department-affiliated urgent care settings: a local urgent care
walk-in clinic; a university-based student health services center; and an urgent care setting located
within a multi-specialty clinic. EMR best practice alerts (BPA) were developed based on Centers
for Disease Control and Prevention (CDC) guidelines and populated on registered patients who
qualified to receive HIV and/or HCV testing. Patients were excluded from the study if they chose to
opt out from testing or the provider deemed it clinically inappropriate. Upon notification of a positive
HIV and/or HCV test result through the EMR, patient navigators (PNs) were responsible for linking
patients to their first medical appointment.
Results: From June 2017 through May 2018, 48,531 patients presented to the three urgent care
clinics. Out of 27,230 eligible patients, 1,972 patients (7.2%) agreed to be screened for HIV; for
HCV, out of 6,509 eligible patients, 1,895 (29.1%) agreed to be screened. Thirty-one patients
(1.6%) screened antibody-positive for HCV, with three being ribonucleic acid confirmed positives.
No patients in either setting were confirmed positive for HIV; however, two initially screened HIVpositive. PNs were able to link 17 HCV antibody-positive patients (55%) to their first appointment,
with the remainder having a scheduled future appointment.
Conclusion: Introducing an EMR-based screening program is an effective method to identify
and screen eligible patients for HIV and HCV in Appalachian urgent care settings where universal
screenings are not routinely implemented. [West J Emerg Med. 2018;19(6)1057–1064.]

INTRODUCTION
Hepatitis C virus (HCV) significantly increases the risk
of developing hepatocellular carcinoma and liver cirrhosis.1
Treatment of HCV-related illnesses is estimated to cost
Volume 19, no. 6: November 2018

approximately $6.5 billion per year in the United States (U.S.).2
Individuals born between 1945 and 1965 currently account for
three-fourths of all HCV infections and are recommended to
have at least one HCV test in their lifetime, according to Centers
1057
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for Disease Control and Prevention (CDC) recommendations.3
Recently, an HCV epidemic related to injection of opioids has led
to a sharp increase in incident cases in the U.S.
Central Appalachia (Kentucky, Tennessee, Virginia, West
Virginia) has been particularly hard hit by this epidemic, with
observed cases of HCV increasing 364% between 2006 and
2012.4,5 A recent study has demonstrated a need for further
HCV testing and intervention in the Appalachian region.6
Among Central Appalachia states, West Virginia currently
has the second-highest incident rate of HCV in the nation.4
Of particular concern is the fact that HCV co-infection
has been observed in rates as high as 90% among human
immunodeficiency virus (HIV) positive injection drug users.7
Although West Virginia has historically had a low HIV
prevalence, there has recently been an alarming increase of
HIV cases in the state.8 This increase, coupled with the HCV
epidemic, demonstrates the need for established screening
efforts to help halt the cycle of transmission of HIV and HCV.7
One plausible location to increase our HIV and HCV
screenings are local, acute care, walk-in clinics where research
has been limited. A recent review of the National Hospital
Ambulatory Medical Care Survey revealed that HIV testing
was significantly greater in outpatient ambulatory medical care
settings than in emergency departments (ED) and physicians’
offices, suggesting that urgent cares may be an important setting
in which to expand testing.9-10 HCV has been identified in
individuals outside of current CDC recommendations for testing,
indicating a need to implement universal screening during patient
visits.11 Multiple studies have demonstrated success in using a
best practice alert (BPA) model, prompting and streamlining
the linkage-to-care process.11,12 Additionally, urgent care clinics
may be an ideal setting for both HIV and HCV screenings, as
physicians may be less constrained by time or patient acuity
compared to the ED setting. To our knowledge, there are no
prior scholarly works discussing the implementation of a dual
HIV-HCV screening program within an urgent care location,
especially within rural Appalachian settings.
The purpose of our study was to implement an electronic
medical record (EMR)-based HIV and HCV screening program
at three of our local urgent care clinics with the primary objective
of using BPAs to enhance a provider’s likelihood of ordering a
test in patients eligible for HIV and HCV screenings. A secondary
objective was to increase the overall number of tests ordered,
adapting from very minimal to routine testing practices.
MATERIALS and METHODS
Study Population and Clinical Sites
The three locations used for the implementation of
HIV and HCV screenings were two local urgent care clinics
(one stand alone and one multi-specialty based) and a student
health services clinic affiliated with a large, mid-Atlantic
university. The urgent care clinic typically sees approximately
24,000 patients per year of all ages, with an average
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What do we already know about this issue?
There is a need for increased Hepatitis C
(HCV) testing in conjunction with CDC
guidelines in the Appalachian region, due
to the high co-infection rates among HIVpositive injection drug users.
What was the research question?
Is an electronic medical record-based
screening program an effective method to
identify and screen eligible patients for HIV
and HCV in urgent care centers?
What was the major finding of the study?
HIV and HCV screenings are feasible during
routine urgent care patient visits, with
subsequent successful linkage to care efforts
for positive patients.
How does this improve population health?
Early identification and intervention of HCV
infections may decrease the spread of the
virus while in early stages, reduce HIV coinfection rates, and prevent future epidemics.

throughput time of 49.7 minutes. The student health services
clinic evaluates approximately 70% of the total student
population (~30,000 per year), with an average throughput
time of 36.8 minutes. Student health services also has
approximately 2,000 visits from the general public per year,
including university faculty and staff. Approximately 2-7% of
patients seen in these clinics will have blood drawn as a part
of their care, although a larger proportion receives point-ofcare testing. None of the three walk-in clinics had previously
conducted preventive screenings during routine patient visits.
The three sites represent different demographics.
Although the majority of patients at all three locations have
private-payer insurance (roughly 50%), the percentage of
Medicare/Medicaid vs. self-pay varies between the three
locations and may have affected screening rates. However,
all screenings were free of charge to patients at all three
locations, regardless of their insurance status. HIV and/or
HCV screenings were only performed during a patient visit
if concerns were identified related to current symptoms or
when a patient presented for a sexually transmitted infection
screening. Therefore, the introduction and implementation of
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HIV and HCV screenings into the urgent care settings would
allow for these tests to become a routine part of patient visits,
no longer relying on the clinician-driven method previously
used. This study was given a non-human subjects research
designation by our university’s institutional review board.
The Electronic Medical Record
To introduce routine HIV and HCV screenings into the
urgent care settings, the EMR (Epic® 2015, Epic Systems
Corporation) was used. BPAs, a clinical decision tool, were used
to populate within the charts of registered patients who qualified
to receive the following: 1) only an HIV screening; 2) only an
HCV screening; or 3) both an HIV and HCV screening. The
BPAs were developed based on CDC screening guidelines, which
include a variety of risk factors.13,14 HIV testing is recommended
for patients aged 13-64 years at least once a year as part of routine
healthcare.14 A list of recommended guidelines with risk factors
warranting HCV screening is shown in the Table.
The EMR would identify eligible patients by searching
charts of registered patients to see if they met screening
guidelines and/or had a history of risk factors in the “Problem
List” tab. BPAs appeared on the computer screen within the
EMR upon opening of eligible patients’ charts during their
visit. Upon presentation of a BPA, providers and staff (i.e.,
physicians, nurses, and technicians) could order the suggested
screening tests; if they decided to not order the test(s) for
eligible patients, providers and staff were prompted to choose
one of the following options: “will assess,” “not clinically
appropriate,” or “patient refused” (Figure 1). To prepare for the
implementation providers and staff received education on both
the BPAs and the screening eligibility criteria at staff meetings .

Figure 1. Example of the dual HIV-HCV “best practice alert” that
populates upon patient eligibility, which are seen by providers and
staff at the urgent care locations.
HIV, human immunodeficiency virus; HCV, hepatitis C virus; CDC,
Centers for Disease Control and Prevention

Implementation of Screenings
Routine EMR-based HIV and HCV screenings began
in June 2017 and were free of charge to all eligible patients.
Placards were hung in care rooms, triage areas, and restrooms
to inform patients of the current screenings, providing them
the opportunity to opt out from testing. If eligible, providers
and nursing staff discussed the options of screenings privately
with patients in their respective treatment rooms. In addition
to having the option to opt out from HIV and/or HCV
testing, other exclusions included providers’ decisions on the

Table. Hepatits C screening recommendations and risk factors, per CDC guidelines.13
Guidelines
HCV testing is recommended for those who:

Risk factors
Are adults born from 1945 through 1965 (without prior ascertainment of HCV risk factors)
Are currently injecting drugs
Ever injected drugs, including those who injected once or a few times many years ago
Have certain medical conditions, including persons:
1. who received clotting factor concentrates produced before 1987
2. who were ever on long-term hemodialysis
3. with persistently abnormal alanine aminotransferase levels (ALT)
4. who have HIV infection
Were prior recipients of transfusions or organ transplants, including persons who:
1. were notified that they received blood from a donor who later tested positive for
HCV infection
2. received a transfusion of blood, blood components, or an organ transplant
before July 1992

HCV testing based on a recognized exposure Healthcare, emergency medical, and public safety workers after needle sticks, sharps, or
is recommended for:
mucosal exposures to HCV-positive blood
Children born to HCV-positive women
HCV, Hepatitis C virus; CDC, Centers for Disease Control and Prevention.
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populated BPAs, and patients refusing a venipuncture during
their visit. If patients refused a blood draw, an option for a
third-generation oral fluid HIV antibody test at the student
health services clinic was offered, with results available within
20 minutes. Patients also had the option to opt out from the
oral fluid antibody test, if desired.
Upon patient verbal consent, blood samples or oral
swabs were obtained from eligible patients for HIV and/
or HCV testing. The HIV screening test used is a fourthgeneration combined antigen and antibody chemiluminescent
immunoassay test that reflexes automatically to an antibody
differentiation immunoassay. All positives obtained from the
rapid testing are confirmed with the combined antigen and
antibody testing by the laboratory. The HCV screening test
used is a chemiluminescent microparticle immunoassay
performed on ARCHITECTi®. The test reflexes
automatically to quantitative HCV ribonucleic acid (RNA)
testing if the initial test result is positive. Results were
available within 12 hours.
Patient Navigators and Linkage to Care
Patients were initially contacted by the urgent care
provider with results and follow-up instructions. Upon
receiving notification of a positive HIV and/or HCV screening
result in the EMR “in-basket” pool, PNs then were responsible
for linking patients to their appropriate care needs. PNs would
call patients via phone to discuss 1) that patients had spoken to
a provider and were aware of their results; 2) the availability
of follow-up appointment options; and 3) scheduling their
follow-up appointment with the appropriate clinic.
HCV Linkage-to-care Process
Patients were referred for follow-up appointments with a
university-based, infectious diseases clinic upon an initial HCV
antibody-positive screening result. Regardless of confirmatory
testing status, it can be helpful to counsel patients about riskfactor modification in the event they are currently “negative” for
HCV infection. Therefore, PNs would make initial contact with
HCV antibody-positive patients regardless of confirmatorytest outcomes. Patients could also be referred to a universitybased, behavioral medicine and psychiatry clinic or a digestive
diseases clinic, depending on patient preferences or the
specified care plan of referring providers.
HIV Linkag- to-care Process
Patients who initially screened positive for HIV with a
negative or indeterminate confirmatory test were contacted
and encouraged to have repeat testing in six weeks due to the
risk of early infection. When possible, these patients were
scheduled to return to one of our primary locations. PNs
were responsible for linking confirmed HIV-positive patients
to a university-based, infectious diseases “Positive Health
Clinic” for follow-up appointments.15 The Positive Health
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Clinic provides comprehensive, primary HIV care services
to a largely rural, impoverished, medically underserved area,
where access to care is limited.
Transportation Assistance
In order to support patient linkage to care, PNs offered
transportation assistance and coordination with follow-up
clinic schedulers. PNs would coordinate taxis with patients
who did not have their own means of transportation or
provide information on local bus transit routes close to their
residence. In addition, PNs would offer gasoline gift cards
to those who had a reliable source of transportation but
needed transportation assistance. In terms of scheduling, PNs
worked closely with clinic schedulers in university-based
departments of infectious diseases, and behavioral medicine
and psychiatry, and in the urgent cares to quickly get patients
into follow-up appointments.
Data Analysis
We analyzed collected data descriptively to assess the
progress of the implementation with the goal to provide
feedback to provider and nursing staff. Reports on BPA firings
were also conducted via the EMR to provide feedback to staff.
We tracked counts of the number of patients tested at each
site, as well as counts of the number of positive test results
for HIV and HCV. Rates of positivity for HIV and HCV
screenings were calculated, as well as the linkage-to-care rates
for all positive patients identified at all locations.
RESULTS
Prior to implementation, approximately 1,639 HIV
screenings and 150 HCV screenings were conducted at the
clinics between June 2016—May 2017. The majority of HIV
screenings were rapid tests (86%) and occurred at the student
health services clinic (89%). From June 5, 2017—May 31,
2018, a total of 48,531 patients presented to the three urgent
care clinics, with the majority (51%) presenting to the local,
stand-alone urgent care clinic. The multi-specialty urgent
care clinic began conducting screenings in February 2018,
once it opened in September 2017. The BPAs populated on
36,389 patients eligible for HIV screening (75%). Overall,
3,388 patients (9.3%) refused HIV screenings, with 5,771
patients (15.9%) deemed “not clinically appropriate” through
the BPAs by providers. Additionally, the BPAs populated
on 7,465 patients eligible for HCV screening (24%), with
489 patients (4.2%) deemed “not clinically appropriate’”by
providers. Furthermore, a total of 467 patients (4.0%)
refused HCV screenings.
Of the remaining 27,230 patients eligible, 1,972 agreed to
be screened for HIV (7.2%). Similarly, of the remaining 6,509
patients eligible, 1,895 (29.1%) agreed to be screened for
HCV (Figure 2). The student health services clinic had higher
screening rates for both HIV and HCV compared to the local
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Figure 2. Flowchart of HIV and HCV screenings at all urgent care clinics.
HIV, human immunodeficiency virus; HCV, Hepatitis C virus; RNA; ribonucleic acid.

urgent care clinics, with 70% of all screenings occurring at
student health. Since screenings were not included as part of
the acute sick visit, no initial baseline numbers are available
for preventative health screenings in comparison.
Thirty-one patients (1.6%) screened antibody-positive for
HCV, with three (9.7%) subsequently having a positive RNA
result. The average age of HCV antibody-positive patients
was 25 years, ranging from 18-65 years. All patients with

Volume 19, no. 6: November 2018

antibody-positive HCV results were referred to infectious
diseases for follow-up through our PNs. No patients in any
of the three clinics were confirmed positive for HIV during
this time period. However, two patients had an initial positive
screen with a negative confirmatory result. Our PNs were able
to link 17 patients (55%) to their first appointments during this
time, with the remaining 14 (45%) patients having a scheduled
future appointment.
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DISCUSSION
Our study demonstrated that an EMR-based HIV and
HCV screening program is effective in the Appalachian
urgent care settings. The “opt-out” model of testing allowed
these varying locations to successfully increase screenings
in conjunction with CDC guidelines and increase linkage
to care through the use of PNs. The EMR is effective at
identifying eligible patients to be screened for HIV and
HCV, as demonstrated in the number of BPA firings during
the initial four months.
During the initial implementation, there were relatively
low acceptance rates for both HIV and HCV testing by
our patient population. There are a number of factors as
to why initial patient testing was low. If providers and
staff were choosing “will assess” upon firing of the BPAs,
instead of immediately addressing it, the BPAs would
continue to populate on the same patients until one of the
following occurred: the test was ordered; it was considered
not clinically necessary by the provider; or the patient
refused to be tested. In cases where only “will assess” was
chosen, it is possible that a final decision for the screenings
may not have been addressed, as it was not required for
chart closure. In these cases, documentation for reasoning
was frequently unrecorded. For those patients who were
documented as “not clinically appropriate” or “patient
refusal,” some indicated that they would defer testing, since
no additional blood work was indicated at the time of visit.
With a low percentage of patients typically having
blood drawn during a visit and short throughput times,
patients do not want to spend the “extra” time giving blood.
A practical alternative would be to reinforce the availability
of the oral swab test to those patients, which could help
increase the HIV testing rates. Other patients indicated a
desire to discuss testing with their primary care provider
or felt they were low risk and testing was unnecessary.
Finally, due to the strong, negative stigma still surrounding
HIV and HCV, patients may not want to know if they are
positive for either. In some cases, the tests were ordered
but not directly from the BPA if later decided. Although
there was a comment option on the BPA, it was rarely used
by the providers to capture the additional reasons noted
above. It may be beneficial to require reasoning on the
BPA in order to close the patient chart, as well as enforce
consistent responses from all providers and nursing staff, to
generate the most accurate reports of the BPA results.
BPA fatigue is often a problem in clinical locations due
to multiple documentation requirements. In the urgent care
settings, these BPAs are somewhat limited when compared
to inpatient services and outpatient primary care. Our
current EMR administration has addressed some of these
needs in the background that are not readily apparent to
the practitioner. In these cases, certain documentation is
required prior to chart closure without prompting a BPA

Western Journal of Emergency Medicine

alert. Due to this, our location was likely more successful
than others by implementing this method. Although we
did not survey staff perceptions about the implementation
of routine HIV and HCV testing, physicians, advanced
practice providers, and nursing staff seemed willing
to participate when education of the department was
performed during departmental meetings. Testing was
performed under all providers and orders seemed to
increase with ongoing education.
There were a number of challenges with the EMR.
First, the accuracy and completeness of searchable,
historical data in the EMR affected the accuracy of BPA
firings. If the patient’s past medical history or current
problem list was not up to date, BPAs would populate
unnecessarily or repeatedly in the case of those patients
who had been previously tested. Risk factors that were not
captured by the EMR, such as multiple sexual partners and
injection drug use, represented missed opportunities for
screening. These behaviors were often not addressed in the
patient visits unless indicated by initial patient complaints.
If addressed at a previous visit, the information may have
been documented within the body of the provider note as
free-text and not in a location that could be easily accessed
via the EMR logic for the BPA requirements. Also, BPAs
were initially set to only detect prior blood screenings.
During this study period, past oral HIV antibody testing
was not captured by the BPAs. However, upon review of
the BPA data, patients who had refused initial blood work
but consented for an oral HIV antibody swab were not
counted in the totals; therefore, in future we would like to
adjust the BPA to capture these tests.
Challenges with EMR data have been previously
reported in the literature.16,17 Despite the commonly held
belief that EMRs decrease medical errors by providing
complete patient information and history, inaccuracies and
incompleteness are a frequently occurring problem. One
study found that 25% of patient charts were incomplete,
with the most commonly inaccurate fields being current
medications, medical history, and medical allergies.16
In a study by Tse and You, inaccuracies in medications
were reported in 51% of records.17 While over 91% of
participants had a history summary with eight or less items
present, omissions were reported for one in every five
participants.17 Further work is needed to improve EMR
accuracy, especially when implementing widespread, EMRbased routine screening for infectious diseases.
Since the BPAs were designed around CDC guidelines
for screenings, there is the possibility that some patient
populations could be missed. Of particular interest are
those who are younger than the HCV birth cohort of 5272 years of age. Although baby boomers account for the
majority of existing infections, newly diagnosed HCV
infections are increasing most rapidly among 20-29 year
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olds.14,18 The urgent care providers were recognizing risk
factors not previously noted in the EMR, and thus began
using wider screening efforts than the original BPA design.
For example, if the BPA was triggered by patient eligibility
for an HIV screening, providers would also recommend
an HCV screening to the patient, since they would already
be having blood drawn upon verbal consent. Interestingly,
all of the HCV antibody-positive patients were younger
than the birth cohort, with an average age of 24 years,
ranging from 18-38 years. This may be related to the
HCV epidemic that the Appalachian region is currently
enduring. The initial findings support the need for universal
HCV screenings among this population, since birth cohort
screening does not identify a significant portion of people
infected with HCV.18
PNs played a crucial role in the screening program. All
10 patients (100%) who tested HCV-antibody positive were
successfully scheduled with referrals to infectious diseases
for follow-up. Although 90% of those patients did not have
HCV RNA-positive results, it is important for the patients to
attend their follow-up appointments due to possibly having a
previous infection. These follow-up appointments also present
an opportunity to counsel “negative” patients on risk-factor
modification. Our linkage-to-care rate was significantly higher
than what is currently seen in the literature.19,20 In a recent
EMR review from a large healthcare system, no action was
taken in 30% of patients who tested positive for HCV.16 Other
studies have demonstrated that only about 15% of patients
diagnosed with chronic HCV have received treatment.20 A
possible explanation for our successful linkage-to-care rate
could be the PN transportation assistance. Transportation is a
significant issue with patients in the Appalachian population;
therefore, providing financial assistance has benefitted our
population tremendously.
Their successes notwithstanding, the PNs have faced
a number of challenges. PNs discovered that patients were
more likely to attend their infectious diseases follow-up
appointments if scheduled close to their original urgent
care visit. Initially, PNs and schedulers could get patients
in within four weeks of initial visit. However, both PNs and
schedulers have become more efficient in scheduling these
appointments closer to within two weeks of initial visit.
This has been a common issue for patient care coordinators
in other settings; the longer the delay to getting a follow-up
appointment, the less likely a patient is to attend.18 Patients
who are motivated to seek treatment will sustain this wait;
however, those patients who lack motivation or education are
less likely to wait and will eventually fail to access care.18
Additionally, PNs could only interface with patients when
contact information was available to them in the EMR.
Therefore, if patients did not provide sufficient or correct
contact information upon initial presentation to the clinic,
the PNs could not follow up with them in a timely manner,

Volume 19, no. 6: November 2018

if at all. To improve follow-up we suggest that clinic staff
encourage patients to provide multiple modes of contact
upon registration with front-desk staff at these clinics.
Future Directions and Improvements
Although initial implementation has been successful,
there are many areas to improve and expand upon. First,
patient-reported reasons for not having HIV and/or HCV
screenings conducted during their visit should be documented
in provider and staff notes within the patients’ EMR. This
would allow tracking of patient perceptions. Similarly,
surveying all patients on their opinions of HIV and HCV
screenings during their visits, regardless of whether or
not they were tested, would increase insight into patient
perceptions. This could provide feedback on the opt-out
process for testing, as well as on the placards hanging in all
treatment rooms and triage locations. Surveying providers
and staff on their opinions and perceptions of the screening
program would be valuable for improving the screening
process. It is crucial to continuously gain feedback from those
on the front lines of implementation in order to best tweak the
program to what will be most efficient for both the patients,
and the providers and nursing staff. It is also important to
have multiple risk factors recorded in easily accessible areas
of the EMR so the BPA will populate accurately.
CONCLUSION
This study has demonstrated the feasibility of introducing
an EMR-based method to identify and screen eligible patients
for HIV and HCV in Appalachian urgent care settings,
successfully transitioning from conducting essentially no
screenings to making this a part of routine patient visits within
a 12-month period. Other urgent or acute care clinics in the
Appalachian region should consider adopting a similar practice
to manage the side effects of the current opioid epidemic.
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